Millennium Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Millennium Management’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-714,100	Closed	-$7.33M	–	6840
2023 Q2	$7.33M	Sell	714,100 -40,000	-5%	-$408K	﹤0.01%	2318
2023 Q1	$7.63M	Sell	754,100 -47,500	-6%	-$478K	﹤0.01%	2222
2022 Q4	$8.01M	Hold	801,600	–	–	﹤0.01%	2372
2022 Q3	$7.8M	Sell	801,600 -76,028	-9%	-$739K	﹤0.01%	2456
2022 Q2	$8.5M	Hold	877,628	–	–	0.01%	2242
2022 Q1	$8.53M	Sell	877,628 -23,972	-3%	-$232K	﹤0.01%	2323
2021 Q4	$8.85M	Sell	901,600 -1,289	-0.1%	-$12.6K	﹤0.01%	2281
2021 Q3	$8.88M	Buy	+902,889	New	+$8.92M	0.01%	2225

Millennium Management's DALS Position: Q3 2023 in Review

Millennium Management sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 714,100 shares — an estimated $7.33M sold.

Millennium Management first reported a position in DALS in Q3 2021 and held it in 8 quarters. The position peaked at $8.88M in Q3 2021. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Millennium Management reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Millennium Management sold 714,100 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $7.33M.
Millennium Management first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 8 quarters.
Millennium Management's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $8.88M in Q3 2021.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.